+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | N-VelcroVax HBcAg in complex with SUMO-gp1 (T=4 VLP) | |||||||||
![]() | Map filtered according to local resolution. | |||||||||
![]() |
| |||||||||
![]() | velcrovax / hepatitis b virus / hepatitis b core antigen / affimer / vaccine / recombinant / vlp / antigen display / virus like particle | |||||||||
Biological species | synthetic construct (others) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.5 Å | |||||||||
![]() | Fatema K / Snowden JS / Watson A / Sherry L / Ranson NA / Stonehouse NJ / Rowlands DJ | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture. Authors: Kaniz Fatema / Joseph S Snowden / Alexander Watson / Lee Sherry / Neil A Ranson / Nicola J Stonehouse / David J Rowlands / ![]() Abstract: Nanoparticle presentation systems offer the potential to develop new vaccines rapidly in response to emerging diseases, a public health need that has become increasingly evident in the wake of the ...Nanoparticle presentation systems offer the potential to develop new vaccines rapidly in response to emerging diseases, a public health need that has become increasingly evident in the wake of the COVID-19 pandemic. Previously, we reported a nanoparticle scaffold system termed VelcroVax. This was constructed by insertion of a high affinity SUMO binding protein (Affimer), able to recognise a SUMO peptide tag, into the major immunodominant region of VLPs assembled from a tandem (fused dimer) form of hepatitis B virus (HBV) core protein (HBc). Here we describe an alternative form, termed N-VelcroVax, a VLP vaccine platform assembled from a monomeric HBc protein (N-anti-SUMO Affimer HBc 190) with the Affimer inserted at the N-terminus. In contrast to the tandem form of VelcroVax, N-VelcroVax VLPs were expressed well in E. coli. The VLPs effectively bound SUMO-tagged Junín virus glycoprotein, gp1 as assessed by structural and serological analyses. Cryo-EM characterisation of N-VelcroVax complexed with a SUMO-Junín gp1 showed continuous density attributable to the fused Affimer, in addition to evidence of target antigen capture. Collectively, these data suggest that N-VelcroVax has potential as a versatile next generation vaccine scaffold. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 298.4 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 38.6 KB 38.6 KB | Display Display | ![]() |
Images | ![]() | 181.8 KB | ||
Masks | ![]() ![]() | 536.4 MB 536.4 MB | ![]() | |
Filedesc metadata | ![]() | 5.3 KB | ||
Others | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | 426.1 MB 486.4 MB 264.9 MB 120.1 MB 496.4 MB 424.7 MB 424.7 MB 297.4 MB 263.2 MB 103.8 MB 426.7 MB 426.7 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 165.2 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 164.7 KB | Display | |
Data in XML | ![]() | 573 B | Display | |
Data in CIF | ![]() | 484 B | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
-
Links
EMDB pages | ![]() ![]() |
---|
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Map filtered according to local resolution. | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.065 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
+Mask #1
+Mask #2
+Additional map: Unsharpened map from symmetrised 3D refinement.
+Additional map: Sharpened map (without mask applied) derived from asymmetric...
+Additional map: Local resolution values for colouring map by local resolution.
+Additional map: Sharpened map (with mask applied).
+Additional map: Sharpened map (without mask applied).
+Additional map: Half map 1 from asymmetric reconstruction of subparticles...
+Additional map: Half map 2 from asymmetric reconstruction of subparticles...
+Additional map: Local resolution-filtered map derived from from asymmetric reconstruction...
+Additional map: Local resolution values for local resolution-based colouring of...
+Additional map: Sharpened map (with mask applied) derived from asymmetric...
+Half map: Half map 1.
+Half map: Half map 2.
-
Sample components
-Entire : T=4 virus-like particle of N-VelcroVax HBcAg in complex with SUMO...
Entire | Name: T=4 virus-like particle of N-VelcroVax HBcAg in complex with SUMO-tagged gp1 from JUNV |
---|---|
Components |
|
-Supramolecule #1: T=4 virus-like particle of N-VelcroVax HBcAg in complex with SUMO...
Supramolecule | Name: T=4 virus-like particle of N-VelcroVax HBcAg in complex with SUMO-tagged gp1 from JUNV type: complex / ID: 1 / Parent: 0 |
---|---|
Source (natural) | Organism: synthetic construct (others) |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Buffer | pH: 7.4 |
---|---|
Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Average electron dose: 54.7 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.9 µm / Nominal defocus min: 0.5 µm |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
-
Image processing
Startup model | Type of model: INSILICO MODEL |
---|---|
Final reconstruction | Applied symmetry - Point group: I (icosahedral) / Resolution.type: BY AUTHOR / Resolution: 3.5 Å / Resolution method: FSC 0.143 CUT-OFF / Number images used: 57537 |
Initial angle assignment | Type: MAXIMUM LIKELIHOOD |
Final angle assignment | Type: MAXIMUM LIKELIHOOD |